Ahead of polling day, Medicines for Ireland (MFI) warmly welcomes the inclusion of several of its key priorities in the manifestos and policy papers of
Medicines for Ireland, alongside our colleagues in Medicines for Europe, are seriously concerned about the impact of the Urban Wastewater Treatment Directive (UWWTD). The direct
Medicines for Europe marks 30 years of delivering more equitable access to off-patent medicines as it opens its annual European conference in Dublin, in partnership with Medicines for Ireland
Suppliers of generic, biosimilar, and value-added medicines call for reform of EU pharmaceutical laws to ensure equitable access to treatments for all patients Increased penetration
Suppliers of generic, biosimilar and value-added medicines unveil vision to enhance patient access and affordability, secure a resilient supply chain, and embed sustainable practices by 2029.
We are committed to working with key stakeholders to affect real change and reforms that ensure Irish patients receive the best medical treatment in the most affordable way.
